​

Funding Round

Series C - NeuroFlow

Series C - NeuroFlow

Investment Firm

Overview

NeuroFlow is a HIPAA compliant digital health platform that optimizes the way behavioral healthcare is delivered, tracked, and assessed.

Announced Date

Oct 12, 2022

Funding Type

Series C

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

SEMCAP

SEMCAP

SEMCAP is a late_stage_venture and private_equity and secondary_market firm.

Participant Investors

3

Investor Name
Participant InvestorWhat If Ventures
Participant InvestorSEMCAP
Participant InvestorStony Lonesome Group

Round Details and Background

NeuroFlow raised $25000000 on 2022-10-12 in Series C

NeuroFlow is a HIPAA compliant digital health platform that optimizes the way behavioral healthcare is delivered, tracked, and assessed.

Company Funding History

10

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 12, 2022
Series C - NeuroFlow
3-25.0M
Sep 19, 2022
Grant - NeuroFlow
1-750.0K
Sep 06, 2023
Venture Round - NeuroFlow
1-undefined
Oct 18, 2017
Seed Round - NeuroFlow
3-1.3M

Recent Activity

There is no recent news or activity for this profile.